| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1475-1313.2012.00914.X |
| P698 | PubMed publication ID | 22620493 |
| P50 | author | Catey Bunce | Q28039205 |
| Michael D. Crossland | Q50541096 | ||
| Catherine A Egan | Q64158704 | ||
| P2093 | author name string | Gary S Rubin | |
| Hannah M P Dunbar | |||
| P2860 | cites work | Leading causes of certification for blindness and partial sight in England & Wales | Q21257225 |
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| Global estimates of the prevalence of diabetes for 2010 and 2030 | Q29547218 | ||
| Subgroup analysis and other (mis)uses of baseline data in clinical trials | Q30588628 | ||
| Fixation stability and reading speed in patients with newly developed macular disease. | Q31086304 | ||
| Patient-centred measurement in ophthalmology--a paradigm shift | Q33246797 | ||
| Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema | Q33269011 | ||
| Statistics notes. Treatment allocation in controlled trials: why randomise? | Q33604598 | ||
| Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment | Q33643905 | ||
| Description and measurement of handicap caused by vision impairment | Q33731767 | ||
| Treatment allocation by minimisation | Q33936213 | ||
| Minimization, by its nature, precludes allocation concealment, and invites selection bias | Q34091576 | ||
| Visual function assessment questionnaires | Q34293016 | ||
| Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy | Q34472219 | ||
| An epidemiological overview of diabetes across the world | Q34585144 | ||
| Low vision services for vision rehabilitation in the United Kingdom | Q34708096 | ||
| Grading and disease management in national screening for diabetic retinopathy in England and Wales | Q35591048 | ||
| Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial | Q35592624 | ||
| Unregistered visual impairment: is registration a failing system? | Q35593495 | ||
| Psychometric properties of vision-related quality of life questionnaires: a systematic review | Q35823559 | ||
| Allocation of patients to treatment groups in a controlled clinical study | Q36042217 | ||
| Making trials matter: pragmatic and explanatory trials and the problem of applicability | Q37236900 | ||
| Unrecognised and unregistered visual impairment | Q37308459 | ||
| The efficacy of low vision device training in a hospital-based low vision clinic | Q37788462 | ||
| Power and sample size calculations. A review and computer program | Q37879786 | ||
| How effective is low vision service provision? A systematic review. | Q37948368 | ||
| Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT). | Q38390326 | ||
| New standardised texts for assessing reading performance in four European languages. | Q38408336 | ||
| Treatment allocation methods in clinical trials: a review | Q39825848 | ||
| Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. | Q40000022 | ||
| Barriers to accessing low vision services | Q40578717 | ||
| Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators | Q42686675 | ||
| Minimisation: the platinum standard for trials?. Randomisation doesn't guarantee similarity of groups; minimisation does | Q42757892 | ||
| A revolution in Welsh low vision service provision. | Q43006960 | ||
| Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy | Q43299871 | ||
| United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. | Q43810405 | ||
| The Veterans Affairs Low Vision Intervention Trial (LOVIT): design and methodology | Q45332128 | ||
| Diabetic retinopathy and health-related quality of life | Q45332675 | ||
| Access and utilization of a new low-vision rehabilitation service | Q45386167 | ||
| Visual fields correlate better than visual acuity to severity of diabetic retinopathy | Q46784375 | ||
| Visual disability variables. I: the importance and difficulty of activity goals for a sample of low-vision patients. | Q48488536 | ||
| Early detection of changes in visual function in diabetes mellitus. | Q50523409 | ||
| The impact of diabetic retinopathy on participation in daily living. | Q51944197 | ||
| Testing for baseline balance in clinical trials. | Q52371295 | ||
| CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. | Q52904789 | ||
| Minimization: A new method of assigning patients to treatment and control groups | Q52909206 | ||
| Clinical biostatistics. XIV. The purposes of prognostic stratification. | Q52993150 | ||
| Randomised controlled trial of an integrated versus an optometric low vision rehabilitation service for patients with age-related macular degeneration: study design and methodology | Q58487791 | ||
| P433 | issue | 4 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 282-293 | |
| P577 | publication date | 2012-05-24 | |
| P1433 | published in | Ophthalmic and Physiological Optics | Q15759086 |
| P1476 | title | The effect of low vision rehabilitation in diabetic eye disease: a randomised controlled trial protocol. | |
| P478 | volume | 32 |
| Q38834070 | Patient-Centered Outcome Measures to Assess Functioning in Randomized Controlled Trials of Low-Vision Rehabilitation: A Review |
| Q97517527 | The efficacy of low vision rehabilitation in improving the quality of life for patients with impaired vision: a systematic review and meta-analysis of 46 randomized clinical trials |
| Q47567326 | Visual and health outcomes, measured with the activity inventory and the EQ-5D, in visual impairment. |
Search more.